Marchand Institute For Minimally Invasive Surgery

Novel oxytocin receptor antagonists for tocolysis: a systematic review and meta-analysis of the available data on the efficacy, safety, and tolerability of retosiban

Marchand G, Blumrick R, Ruuska AD, Ware K, Masoud AT, King A, Ruther S, Brazil G, Cieminski K, Calteux N, Ulibarri H, Sainz K

Current medical research and opinion · Vol 37 · Issue 9 · pp. 1677-1688 · 1 Sep 2021

DOI: 10.1080/03007995.2021.1944076  |  PubMed 34134590  |  Full text

Cite this

Marchand G, Blumrick R, Ruuska AD, Ware K, Masoud AT, King A, Ruther S, Brazil G, Cieminski K, Calteux N, Ulibarri H, Sainz K. Novel oxytocin receptor antagonists for tocolysis: a systematic review and meta-analysis of the available data on the efficacy, safety, and tolerability of retosiban. Curr Med Res Opin. 2021 Jun 16:1. doi: 10.1080/03007995.2021.1944076. Epub ahead of print. PMID: 34134590.

« All publications  ·  Subscribe via RSS

Marchand G, Blumrick R, Ruuska AD, Ware K, Masoud AT, King A, Ruther S, Brazil G, Cieminski K, Calteux N, Ulibarri H, Sainz K. Novel oxytocin receptor antagonists for tocolysis: a systematic review and meta-analysis of the available data on the efficacy, safety, and tolerability of retosiban. Curr Med Res Opin. 2021 Jun 16:1. doi: 10.1080/03007995.2021.1944076. Epub ahead of print. PMID: 34134590.

Export citation: BibTeX  RIS / EndNote

Published on

by

Follow Our Research

New peer-reviewed papers, meta-analyses and conference presentations in minimally invasive gynecologic surgery.

Browse all 138 publications Subscribe via RSS

Book Appointment